Evolus Inc. (EOLS)
NASDAQ: EOLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.74 0.00%
EOLS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $511.23M
- Forward P/E
- 26.46
- EPS (TTM)
- -$0.53
- Dividend yield
- None
- 52-week range
- 3.86 – 9.31
- Day range
- 7.33 – 7.75
- Volume / Avg
- 595.04K / 907.37K
- Beta
- —
- Shares outstanding
- 66.05M
- Next earnings
- Nov 4, 2026
52-week range
EOLS stock today
On Oct 7, EOLS ended the session at $7.74, adding $0.36 (4.88%), versus the S&P 500's 0.22% decline. Shares are 16.9% below their 52-week high of $9.31, set on Sep 4, 2026 and 100.5% above the 52-week low of $3.86, in the middle of the past year's range. EOLS is up 16.4% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 23.6%.
Evolus has posted a net loss over the last twelve months (EPS of -$0.53), so its P/E ratio is not meaningful. Evolus's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Evolus
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2018
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.14
Evolus peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ARVNArvinas Inc. | 7.45 | +1.92% | $480.68M | vs EOLS |
| CTNMContineum Therapeutics Inc. Class A | 12.73 | +0.63% | $478.92M | vs EOLS |
| ACRSAclaris Therapeutics Inc. | 3.40 | -8.11% | $500.48M | vs EOLS |
| CBIOCrescent Biopharma Inc. | 13.49 | -0.59% | $501.11M | vs EOLS |
| CAPRCapricor Therapeutics Inc. | 8.10 | +4.52% | $470.93M | vs EOLS |
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs EOLS |
| ASMBAssembly Biosciences Inc. | 22.95 | +3.47% | $467.28M | vs EOLS |
| DRUGBright Minds Biosciences Inc. | 52.00 | +7.77% | $512.93M | vs EOLS |
Indexes, lists and sector
Largest Health Care stocks
Evolus stock FAQ
What is Evolus's stock price today?
EOLS last traded at $7.74 as of Oct 7, 4:00 PM EDT, up 4.88% on the day. Prices are delayed at least 15 minutes.
When is Evolus's next earnings date?
Evolus is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.14.
What is the EOLS 52-week high?
The 52-week high for EOLS is $9.31 and the 52-week low is $3.86. The stock is currently 16.9% below its high.